GNAS1 mutations occur more commonly than previously thought in intramuscular myxoma
- 1 May 2009
- journal article
- research article
- Published by Elsevier in Laboratory Investigation
- Vol. 22 (5) , 718-724
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Replacing PCR with COLD-PCR enriches variant DNA sequences and redefines the sensitivity of genetic testingNature Medicine, 2008
- Detection of β-Catenin Mutations in Paraffin-embedded Sporadic Desmoid-type Fibromatosis by Mutation-specific Restriction Enzyme Digestion (MSRED): an Ancillary Diagnostic ToolAmerican Journal of Surgical Pathology, 2007
- A sensitive mutation‐specific screening technique for GNAS1 mutations in cases of fibrous dysplasia: the first report of a codon 227 mutation in boneHistopathology, 2007
- KRAS Mutation Status Is Predictive of Response to Cetuximab Therapy in Colorectal CancerCancer Research, 2006
- KRAS Mutations and Primary Resistance of Lung Adenocarcinomas to Gefitinib or ErlotinibPLOS Medicine, 2005
- Activating Gsα mutation in intramuscular myxomas with and without fibrous dysplasia of boneVirchows Archiv, 2000
- GTPase inhibiting mutations activate the α chain of Gs and stimulate adenylyl cyclase in human pituitary tumoursNature, 1989
- Intramuscular Myxoma—A Clinicopathological Study of Twenty-Three CasesAmerican Journal of Clinical Pathology, 1985
- Intramuscular Myxoma: A Review and Follow-Up Study of 34 CasesAmerican Journal of Clinical Pathology, 1965
- Syndrome Characterized by Osteitis Fibrosa Disseminata, Areas of Pigmentation and Endocrine Dysfunction, with Precocious Puberty in FemalesNew England Journal of Medicine, 1937